Product Information
LAYOLIS FE CHEWABLE TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $1.6438 per EA under NDC 52544006431. Its NADAC has been published 556 times since Aug 12, 2015.
Manufacturer
Actavis Pharma, Inc.NDC
52544006431
Classification
Generic
Dosage Form
KIT
Route
ORAL
Last Updated
3/18/2026
Approval Type
Authorized Generic (NDA)
FDA Application
NDA022573On Market Since
12/23/2011
Price Statistics
The NADAC for LAYOLIS FE CHEWABLE TABLET has been published 556 times since Aug 12, 2015, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6438 per EA |
|---|---|
| All-time high | $4.3997 (Jan 11, 2017) |
| All-time low | $0.9745 (Feb 21, 2024) |
| 52-week high | $1.8990 |
| 52-week low | $1.6438 |
| Median price | $2.1350 |
| Average price | $2.2963 |
| Largest weekly change | +54.1% (Sep 22, 2021) |
| Weeks tracked | 556 |
| Tracking since | Aug 12, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the norethindrone, ethinyl estradiol, and ferrous fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LAYOLIS FE CHEWABLE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAYOLIS FE CHEWABLE TABLET, manufactured by Actavis Pharma, Inc., is $1.6438 per EA (NDC 52544006431), effective Apr 1, 2026.
How has the price of LAYOLIS FE CHEWABLE TABLET changed over time?
Over the history we have for it, the NADAC for LAYOLIS FE CHEWABLE TABLET has declined 58.1%. It has been tracked across 556 weekly CMS publications since Aug 12, 2015.
What are the highest and lowest recorded NADAC prices for LAYOLIS FE CHEWABLE TABLET?
Since Aug 12, 2015, the NADAC for LAYOLIS FE CHEWABLE TABLET has ranged from a low of $0.9745 (Feb 21, 2024) to a high of $4.3997 (Jan 11, 2017), with a median of $2.1350 per EA.
Are there cheaper alternatives to LAYOLIS FE CHEWABLE TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LAYOLIS FE CHEWABLE TABLET, so no direct lower-cost alternative is listed.
Who manufactures LAYOLIS FE CHEWABLE TABLET?
LAYOLIS FE CHEWABLE TABLET (NDC 52544006431) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification